Literature DB >> 10671696

Alterations in the retinoblastoma pathway of cell cycle control in parathyroid tumors.

I Szijan1, I Orlow, V Dalamon, P Vergani, K Danilowicz, N Mezzadri, C Cordon-Cardo, O D Bruno.   

Abstract

Mutations in proto-oncogenes and tumor suppressor genes have been associated with tumor development and/or progression in many neoplasms. It has been reported that parathyroid tumors have deletions affecting the retinoblastoma gene (RB), and overexpression of cyclin D1 (Cyc D1). The aim of the present study was to evaluate the alterations in the components of the pRB pathway in parathyroid adenomas and parathyroid aggressive tumors, including patterns of expression of pRB, Cyc D1, and p16/INK4A. Paired normal and tumor DNA from 6 parathyroid adenomas and 5 aggressive tumors were analyzed for loss of heterozygosity (LOH) at the RB locus. The expression of pRB, Cyc D1 and p16 was studied in 4 adenomas and 5 aggressive tumors. RB LOH was found in 1 of 6 adenomas, and in 1 of 2 informative aggressive tumors. Immunohistochemical analysis revealed undetectable pRB in 4 of 5 aggressive tumors and presence of pRB in all adenomas. Conversely, Cyc D1 expression was found in 3 of 4 aggressive tumors, but was undetectable in the adenomas. Expression of p16 was identified only in one aggressive tumor. Thus, alterations in the pRB pathway seem to prevail in the aggressive form of parathyroid neoplasms. Our results warrant further investigation of these cell cycle regulators in order to determine their potential role as tumor markers in parathyroid tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671696     DOI: 10.3892/or.7.2.421

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Expression of p16(INK4A) gene in human pituitary tumours.

Authors:  Gloria Machiavelli; Javier Cotignola; Karina Danilowicz; Carolina Carbonara; Andrea Paes de Lima; Armando Basso; Oscar Domingo Bruno; Irene Szijan
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  Genetic Variants Associated with Circulating Parathyroid Hormone.

Authors:  Cassianne Robinson-Cohen; Pamela L Lutsey; Marcus E Kleber; Carrie M Nielson; Braxton D Mitchell; Joshua C Bis; Karen M Eny; Laura Portas; Joel Eriksson; Mattias Lorentzon; Daniel L Koller; Yuri Milaneschi; Alexander Teumer; Stefan Pilz; Maria Nethander; Elizabeth Selvin; Weihong Tang; Lu-Chen Weng; Hoi Suen Wong; Dongbing Lai; Munro Peacock; Anke Hannemann; Uwe Völker; Georg Homuth; Matthias Nauk; Federico Murgia; Jack W Pattee; Eric Orwoll; Joseph M Zmuda; Jose Antonio Riancho; Myles Wolf; Frances Williams; Brenda Penninx; Michael J Econs; Kathleen A Ryan; Claes Ohlsson; Andrew D Paterson; Bruce M Psaty; David S Siscovick; Jerome I Rotter; Mario Pirastu; Elizabeth Streeten; Winfried März; Caroline Fox; Josef Coresh; Henri Wallaschofski; James S Pankow; Ian H de Boer; Bryan Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2016-12-07       Impact factor: 14.978

Review 3.  Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.

Authors:  Luís Cardoso; Mark Stevenson; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2017-09-25       Impact factor: 4.878

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.